Top

Published in:

01-02-2017 | Brief Report

Epidemiology and etiology of hand, foot, and mouth disease in Fujian province, 2008-2014

Authors: Yuwei Weng, Wei Chen, Meng Huang, Wenxiang He, Kuicheng Zheng, Yansheng Yan

Published in: Archives of Virology | Issue 2/2017

Abstract

Millions of cases of hand, foot, and mouth disease (HFMD) have been reported annually in mainland China since 2008. In this study, we investigated the epidemiology and etiology of an HFMD epidemic in Fujian province, which is located in subtropical southeastern China. Our study found similar epidemiological features of HFMD in southern areas of China, including seasonality and demographic distribution, as well as correlation between severity of illness and serotype. At least 22 serotypes of other enterovirus co-circulating with enterovirus 71 were found to belong to clade C4a, and those circulating with coxsackievirus A16 were associated with clades B1a and B1b.

Available only for authorised users

Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T (2010) Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 9:1097–1105CrossRefPubMed

Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE (2003) Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9:78–85CrossRefPubMedPubMedCentral

Herrero LJ, Lee CS, Hurrelbrink RJ, Chua BH, Chua KB, McMinn PC (2003) Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997–2000. Arch Virol 148:1369–1385CrossRefPubMed

Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341:929–935CrossRefPubMed

He YQ, Feng SJ, Liu K, Yang H (2003) Surveillance of Enterovirus Type 71 in shenzhen in 2001. Dis Surveill 18:287–289

Lin SE, Zhang Q, Xie HP, Xie JP, He JX, Dong QL, Fang ZY (2004) Phylogenetic analysis of enterovirus 71 isolated from patients with hand, foot and mouth disease in Guangdong and Fujian provinces 2000–2001. Zhong hua shi yan he lin chuang bing du xue za zhi 18:227–229

Zheng ZM, Zhang JH, Zhu WP, He PJ (1989) Isolation of enterovirus type 71 from the vesicle fluid of an adult patient with hand-foot-mouth disease in China. Virol Sin 4:375–382

Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J (2009) Enterovirus 71 outbreak in the People’s Republic of China in 2008. J Clin Microbiol 47:2351–2352CrossRefPubMedPubMedCentral

Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, An HQ, Li DX, Wang SW, Xu AQ, Wang ZJ, Xu WB (2009) An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol Off Publ Pan Am Soc Clin Virol 44:262–267CrossRef

10.

Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease C, Prevention (2006) Enterovirus surveillance–United States, 1970–2005. Morb Mortal Wkly Rep Surveill Summ 55:1–20

11.

Pallansch MA, Oberste MS, Whittion JL (2013) Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses, 6th edn. Lippincott Williams & Wilkins, USA

12.

Wang Y, Feng Z, Yang Y, Self S, Gao Y, Longini IM, Wakefield J, Zhang J, Wang L, Chen X, Yao L, Stanaway JD, Wang Z, Yang W (2011) Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology 22:781–792CrossRefPubMedPubMedCentral

13.

Deng T, Huang Y, Yu S, Gu J, Huang C, Xiao G, Hao Y (2013) Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province, China. PloS One 8:e56943CrossRefPubMedPubMedCentral

14.

Ni H, Yi B, Yin J, Fang T, He T, Du Y, Wang J, Zhang H, Xie L, Ding Y, Gu W, Zhang S, Han Y, Dong H, Su T, Xu G, Cao G (2012) Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008–2011. J Clin Virol Off Publ Pan Am Soc Clin Virol 54:342–348CrossRef

15.

Zhuang ZC, Kou ZQ, Bai YJ, Cong X, Wang LH, Li C, Zhao L, Yu XJ, Wang ZY, Wen HL (2015) Epidemiological research on hand, foot, and mouth disease in mainland China. Viruses 7:6400–6411CrossRefPubMedPubMedCentral

16.

Oberste MS, Maher K, Williams AJ, Dybdahl-Sissoko N, Brown BA, Gookin MS, Penaranda S, Mishrik N, Uddin M, Pallansch MA (2006) Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. J Gen Virol 87:119–128CrossRefPubMed

17.

Oberste MS, Nix WA, Maher K, Pallansch MA (2003) Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol Off Publ Pan Am Soc Clin Virol 26:375–377CrossRef

18.

Liu W, Wu S, Xiong Y, Li T, Wen Z, Yan M, Qin K, Liu Y, Wu J (2014) Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PloS One 9:e96051CrossRefPubMedPubMedCentral

19.

Zhang Y, Tan X, Cui A, Mao N, Xu S, Zhu Z, Zhou J, Shi J, Zhao Y, Wang X, Huang X, Zhu S, Zhang Y, Tang W, Ling H, Xu W (2013) Complete genome analysis of the C4 subgenotype strains of enterovirus 71: predominant recombination C4 viruses persistently circulating in China for 14 years. PloS One 8:e56341CrossRefPubMedPubMedCentral

20.

Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, Zhang Y, Yan D, Li Q, Dong X, Zhang J, Zhao Y, Wan J, Feng Z, Sun J, Wang S, Li D, Xu W (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7:94CrossRefPubMedPubMedCentral

21.

Chen X, Tan X, Li J, Jin Y, Gong L, Hong M, Shi Y, Zhu S, Zhang B, Zhang S, Zhang Y, Mao N, Xu W (2013) Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PloS One 8:e82861CrossRefPubMedPubMedCentral

22.

Guan H, Wang J, Wang C, Yang M, Liu L, Yang G, Ma X (2015) Etiology of multiple non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009-June 2013. PloS One 10:e0142733CrossRefPubMedPubMedCentral

23.

Yang XH, Yan YS, Weng YW, He AH, Zhang HR, Chen W, Xu JY, Lin QC, Zhou Y (2012) Molecular analysis of echovirus 30 responsible for the outbreak of aseptic meningitis in Fujian Province, 2011. Chin J Zoonosis 28:265–269

24.

Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA (1999) Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37:1288–1293PubMedPubMedCentral

25.

Cabrerizo M, Tarrago D, Munoz-Almagro C, Del Amo E, Dominguez-Gil M, Eiros JM, Lopez-Miragaya I, Perez C, Reina J, Otero A, Gonzalez I, Echevarria JE, Trallero G (2014) Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20:O150–O156

26.

Yan X, Zhang ZZ, Yang ZH, Zhu CM, Hu YG, Liu QB (2015) Clinical and etiological characteristics of atypical hand-foot-and-mouth disease in children from Chongqing, China: a retrospective study. Biomed Res Int 2015:802046PubMedPubMedCentral

27.

Liang Z, Mao Q, Gao F, Wang J (2013) Progress on the research and development of human enterovirus 71 (EV71) vaccines. Front Med 7:111–121CrossRefPubMed

28.

Mao Q, Cheng T, Zhu F, Li J, Wang Y, Li Y, Gao F, Yang L, Yao X, Shao J, Xia N, Liang Z, Wang J (2013) The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PloS One 8:e79599CrossRefPubMedPubMedCentral

29.

Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC (2012) Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccines Immunother 8:668–674CrossRef

30.

Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, Hu YM, Wu X, Liu P, Zhu LY, Gao F, Jin H, Chen YJ, Dong YY, Liang YC, Shi NM, Ge HM, Liu L, Chen SG, Ai X, Zhang ZY, Ji YG, Luo FJ, Chen XQ, Zhang Y, Zhu LW, Liang ZL, Shen XL (2013) Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381:2024–2032CrossRefPubMed

31.

Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, Cowling BJ, Varma JK, Farrar JJ, Leung GM, Yu H (2014) Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis 14:308–318CrossRefPubMedPubMedCentral

32.

Carrat F, Flahault A (2007) Influenza vaccine: the challenge of antigenic drift. Vaccine 25:6852–6862CrossRefPubMed

Title: Epidemiology and etiology of hand, foot, and mouth disease in Fujian province, 2008-2014
Authors: Yuwei Weng
Wei Chen
Meng Huang
Wenxiang He
Kuicheng Zheng
Yansheng Yan
Publication date: 01-02-2017
Publisher: Springer Vienna
Published in: Archives of Virology / Issue 2/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-016-3127-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Molecular evidence of Orthopoxvirus DNA in capybara (Hydrochoerus hydrochaeris) stool samples

Development and evaluation of a reverse transcription loop-mediated isothermal amplification assay for detection of beet necrotic yellow vein virus

Characterization of a soybean mosaic virus variant causing different diseases in Glycine max and Nicotiana benthamiana

Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus

Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine

Complete nucleotide sequence of a new variant of grapevine fanleaf virus from northeastern China

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials